Induction of CD4+ T-cell anergy and apoptosis by activated human B cells

Blood

Volumn 112, Issue 12, 2008, Pages 4555-4564

  Tretter, Theresa ^a   Venigalla, Ram K C ^a   Eckstein, Volker ^a   Saffrich, Rainer ^a   Sertel, Serkan ^a   Ho, Anthony D ^a   Lorenz, Hanns Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL CYCLE ARREST; CELL DIVISION; CELL ENERGY; CELL INTERACTION; CELL STIMULATION; CELL SUBPOPULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; CELL CULTURE; CELL PROLIFERATION; CLONAL ANERGY; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; UPREGULATION;

APOPTOSIS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELL PROLIFERATION; CELLS, CULTURED; CLONAL ANERGY; HUMANS; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; UP-REGULATION;

EID: 58149402498     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-02-140087     Document Type: Article

References (54)

1. Sakaguchi S, Ono M, Setoguchi R, et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006;212:8-27.
2. Clark EA, Ledbetter JA. How B and T cells talk to each other. Nature. 1994;367:425-428.
3. Gray D, Gray M, Barr T. Innate responses of B cells. Eur J Immunol. 2007;37:3304-3310.
4. Eynon EE, Parker DC. Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J Exp Med. 1992;175: 131-138.
5. Fuchs EJ, Matzinger P. B cells turn off virgin but not memory T cells. Science. 1992;258:1156-1159.
6. Stockinger B, Zal T, Zal A, Gray D. B cells solicit their own help from T cells. J Exp Med. 1996;183: 891-899.
7. Serreze DV, Chapman HD, Varnum DS, et al. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice. J Exp Med. 1996;184:2049-2053.
8. Martin F, Chan AC. Pathogenic roles of B cells in human autoimmunity: insights from the clinic. Immunity. 2004;20:517-527.
9. Olson TS, Bamias G, Naganuma M, et al. Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease. J Clin Invest. 2004;114:389-398.
10. Serra P, Santamaria P. To 'B' regulated: B cells as members of the regulatory workforce. Trends Immunol. 2006;27:7-10.
11. Knoechel B, Lohr J, Kahn E, Abbas AK. The link between lymphocyte deficiency and autoimmunity: roles of endogenous T and B lymphocytes in tolerance. J Immunol. 2005;175:21-26.
12. Wolf SD, Dittel BN, Hardardottir F, Janeway CA Jr. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med. 1996;184:2271-2278.
13. MizoguchiA, Mizoguchi E, Smith RN, Preffer FI, Bhan AK. Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J Exp Med. 1997;186:1749-1756.
14. Jankovic D, Cheever AW, Kullberg MC, et al. CD4+ Tcell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signaling. J Exp Med. 1998;187:619-629.
15. Lundy SK, Berlin AA, Martens TF, Lukacs NW. Deficiency of regulatory B cells increases allergic airway inflammation. Inflamm Res. 2005;54: 514-521.
16. Hernandez HJ, Wang Y, Stadecker MJ. In infection with Schistosoma mansoni, B cells are required for T helper type 2 cell responses but not for granuloma formation. J Immunol. 1997;158: 4832-4837.
17. Tian J, Zekzer D, Hanssen L, et al. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol. 2001;167: 1081-1089.
18. Mauri C, Gray D, Mushtaq N, Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med. 2003;197:489-501.
19. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d up-regulation. Immunity. 2002;16:219-230.
20. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol. 2002;3:944-950.
21. Parekh VV, Prasad DV, Banerjee PP, et al. B cells activated by lipopolysaccharide, but not by anti-Ig and anti-CD40 antibody, induce anergy in CD8+ Tcells: role of TGF-beta 1. J Immunol. 2003;170: 5897-5911.
22. Chen X, Jensen PE. Cutting edge: primary B lymphocytes preferentially expand allogeneic FoxP3+ CD4Tcells. J Immunol. 2007;179:2046-2050.
23. Reichardt P, Dornbach B, Rong S, et al. Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse. Blood. 2007; 110:1519-1529.
24. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25high regulatory cells in human peripheral blood. J Immunol. 2001;167:1245-1253.
25. Scheffold A, Murphy KM, HoferT. Competition for cytokines: T(reg) cells take all. Nat Immunol. 2007;8:1285-1287.
26. Croft M, Joseph SB, Miner KT. Partial activation of naive CD4 T cells and tolerance induction in response to peptide presented by resting B cells. J Immunol. 1997;159:3257-3265.
27. Appleman LJ, Boussiotis VA. T cell anergy and costimulation. Immunol Rev. 2003;192:161-180.
28. Saito T, Yamasaki S. Negative feedback of T cell activation through inhibitory adapters and co-stimulatory receptors. Immunol Rev. 2003;192: 143-160.
29. Pascual V, Liu YJ, Magalski A, et al. Analysis of somatic mutation in five B cell subsets of human tonsil. J Exp Med. 1994;180:329-339.
30. Casamayor-Palleja M, Feuillard J, Ball J, Drew M, MacLennan IC. Centrocytes rapidly adopt a memory B cell phenotype on co-culture with autologous germinal centre T cell-enriched preparations. Int Immunol. 1996;8:737-744.
31. Klein U, la-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol. 2008;8:22-33.
32. Billian G, Bella C, Mondiere P, DefranceT. Identification of atonsil IgD+ B cell subset with phenotypical and functional characteristics of germinal center B cells. Eur J Immunol. 1996;26:1712-1719.
33. Amu S, Tarkowski A, DornerT, Bokarewa M, Brisslert M. The human immunomodulatory CD25+ B cell population belongs to the memory B cell pool. Scand J Immunol. 2007; 66:77-86.
34. Monroe JG, Keir ME. Bridging Toll-like- and B cell-receptor signaling: meet me at the autophagosome. Immunity. 2008;28:729-731.
35. Heikenwalder M, Polymenidou M, Junt T, et al. Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat Med. 2004;10:187-192.
36. Wingender G, Garbi N, Schumak B, et al. Systemic application of CpG-rich DNAsuppresses adaptive T cell immunity via induction of IDO. Eur J Immunol. 2006;36:12-20.
37. Amu S, Stromberg K, Bokarewa M, Tarkowski A, Brisslert M. CD25-expressing B-lymphocytes in rheumatic diseases. Scand J Immunol. 2007;65: 182-191.
38. Odendahl M, Jacobi A, Hansen A, et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol. 2000;165:5970-5979.
39. Green DR, Droin N, Pinkoski M. Activation-induced cell death in T cells. Immunol Rev. 2003; 193:70-81.
40. Choi S, Schwartz RH. Molecular mechanisms for adaptive tolerance and other T cell anergy models. Semin Immunol. 2007;19:140-152.
41. Wells AD, Walsh MC, Bluestone JA, Turka LA. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J Clin Invest. 2001; 108:895-903.
42. Lundy SK, Lerman SP, Boros DL. Soluble egg antigen-stimulated T helper lymphocyte apoptosis and evidence for cell death mediated by FasL(+) T and B cells during murine Schistosoma mansoni infection. Infect Immun. 2001; 69:271-280.
43. Hahne M, RennoT, Schroeter M, et al. Activated B cells express functional Fas ligand. Eur J Immunol. 1996;26:721-724.
44. Bennett SR, Carbone FR,ToyT, Miller JF, Heath WR. B cells directlytolerize CD8(+)Tcells. J Exp Med. 1998;188:1977-1983.
45. Hildeman D, JorgensenT, Kappler J, Marrack P. Apoptosis and the homeostatic control of immune responses. Curr Opin Immunol. 2007;19:516-521.
46. Strasser A, Pellegrini M. T-lymphocyte death during shutdown of an immune response. Trends Immunol. 2004;25:610-615.
47. Unsinger J, Herndon JM, Davis CG, et al. The role of TCR engagement and activation-induced cell death in sepsis-induced T cell apoptosis. J Immunol. 2006;177:7968-7973.
48. Rieux-Laucat F, Le DF, Hivroz C, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science. 1995;268: 1347-1349.
49. Pandiyan P, Zheng L, Ishihara S, Reed J, Lenardo MJ. CD4 + CD25 + Foxp3+ regulatoryT cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol. 2007;8:1353-1362.
50. Pandiyan P, Lenardo MJ. The control of CD4 + CD25 + Foxp3+ regulatoryT cell survival. Biol Direct. 2008;3:6.
51. Hahn HP, Pang M, He J, et al. Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell death. Cell Death Differ. 2004;11:1277-1286.
52. Hildeman DA, Mitchell T, Kappler J, Marrack P. T cell apoptosis and reactive oxygen species. J Clin Invest. 2003;111:575-581.
53. Pettersen RD, Hestdal K, Olafsen MK, Lie SO, Lindberg FP. CD47 signals Tcell death. J Immunol. 1999;162:7031-7040.
54. MalekTR, Bayer AL. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol. 2004;4:665-674.